iRhythm Holdings (IRTC) Cash from Financing Activities (2015 - 2026)

iRhythm Holdings' (IRTC) quarterly Cash from Financing Activities came in at $149000.0 in Q1 2026, down 91.38% year-on-year from $1.7 million in Q1 2025, and down 94.96% on a QoQ basis from $3.0 million in Q4 2025.

iRhythm Holdings (IRTC) Cash from Financing Activities (2015 - 2026) Analysis & Trends

iRhythm Holdings (IRTC) has 12 years of Cash from Financing Activities data on file, last reported at $149000.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 91.38% year-over-year to $149000.0 in Q1 2026; TTM through Mar 2026 was $11.0 million, a 30.2% increase from a year earlier, with the FY2025 full-year figure at $12.6 million, down 97.53% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $149000.0, down from $3.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for IRTC reached as high as $504.6 million in Q1 2024 and fell as low as -$35000.0 in Q3 2024.
  • Historically, Cash from Financing Activities has averaged $32.9 million across 5 years, with a median of $3.0 million in 2024.
  • On a YoY basis, Cash from Financing Activities climbed as much as 55661.44% in 2024 and fell as far as 153.03% in 2024.
  • Year by year, Cash from Financing Activities stood at $3.1 million in 2022, then grew by 10.17% to $3.5 million in 2023, then fell by 13.87% to $3.0 million in 2024, then retreated by 0.94% to $3.0 million in 2025, then plunged by 94.96% to $149000.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $149000.0 in Q1 2026, $3.0 million in Q4 2025, and $825000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 iRhythm Holdings 3.50 Bn 2.95 Bn 141.35 Mn 149,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 149,000.00
Mar 31, 2026 149,000.00
Dec 31, 2025 2.96 Mn
Dec 31, 2025 2.96 Mn
Sep 30, 2025 825,000.00
Sep 30, 2025 825,000.00
Jun 30, 2025 7.09 Mn
Jun 30, 2025 7.09 Mn
Mar 31, 2025 1.73 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 2.99 Mn
Dec 31, 2024 2.99 Mn
Sep 30, 2024 -35,000.00
Sep 30, 2024 -35,000.00
Jun 30, 2024 3.79 Mn
Jun 30, 2024 3.79 Mn
Mar 31, 2024 504.64 Mn
Mar 31, 2024 504.64 Mn
Dec 31, 2023 3.47 Mn
Dec 31, 2023 3.47 Mn